Press Release: Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2025

Dow Jones12-31 05:31

TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited interim consolidated financial results for the three and nine month periods ended September 30, 2025.

Financial Highlights

   -- Total assets as of September 30, 2025 amounted to approximately EUR759.4 
      million, compared to total assets as of December 31, 2024 of 
      approximately EUR677.3 million. 
 
   -- Revenues1 for the three months ended September 30, 2025 were 
      approximately EUR12.7 million, compared to revenues of approximately 
      EUR12.3 million for the three months ended September 30, 2024. Revenues 
      for the nine months ended September 30, 2025 were approximately EUR32.9 
      million, compared to revenues of approximately EUR31.8 million for the 
      nine months ended September 30, 2024. 
 
   -- Profit for the three months ended September 30, 2025 was approximately 
      EUR10.1 million, compared to profit of approximately EUR6.6 million for 
      the three months ended September 30, 2024. Profit for the nine months 
      ended September 30, 2025 was approximately EUR8.5 million, compared to 
      profit of approximately EUR3.3 million for the nine months ended 
      September 30, 2024. 
 
   -- EBITDA for the three months ended September 30, 2025 was approximately 
      EUR22.1 million, compared to EBITDA of approximately EUR11 million for 
      the three months ended September 30, 2024. EBITDA for the nine months 
      ended September 30, 2025 was approximately EUR28.2 million, compared to 
      EBITDA of approximately EUR17.6 million for the nine months ended 
      September 30, 2024. See below under "Use of Non-IFRS Financial Measures" 
      for additional disclosure concerning EBITDA. 

Financial Overview for the Nine Months Ended September 30, 2025

   -- Revenues1 were approximately EUR32.9 million for the nine months ended 
      September 30, 2025, compared to approximately EUR31.8 million for the 
      nine months ended September 30, 2024. The increase in revenues mainly 
      results from revenues generated from the Company's 19.8 MW and 18.1 MW 
      Italian solar facilities that were connected to the grid in February-May 
      2024 and in January 2025, respectively, and from the Company's facilities 
      in the USA that were connected to the grid during the second quarter of 
      2025. Such increase was partly offset by lower revenues from the 
      Company's Dutch biogas plants, one of which experienced a production 
      issue related to the bacteria used by the plant that affected output in 
      January and April 2025 and another facility whose output was adversely 
      affected during the summer months due to high temperatures. In addition, 
      revenues from the Talasol facility were slightly lower in the nine months 
      ended September 30, 2025, due to damage caused by a fire event that 
      occurred in July 2024, that has since been repaired and restored to 
      nearly 97% output, though not yet fully recovered. 
 
   -- Operating expenses were approximately EUR14.4 million for the nine months 
      ended September 30, 2025, compared to approximately EUR14.5 million for 
      the nine months ended September 30, 2024. The decrease in operating 
      expenses mainly results from lower costs in connection with the 
      acquisition of feedstock by the Company's Dutch biogas plants, partially 
      offset by the achievement of preliminary acceptance certificate $(PAC)$ of 
      the Company's 19.8 MW Italian solar facilities subsequent to September 
      30, 2024, upon which the Company commenced recording operating expenses 
      of the solar facilities. Depreciation and amortization expenses were 
      approximately EUR12.9 million for the nine months ended September 30, 
      2025, compared to approximately EUR12.3 million for the nine months ended 
      September 30, 2024. 
 
   -- Project development costs were approximately EUR3.4 million for the nine 
      months ended September 30, 2025, compared to approximately EUR3.3 million 
      for the nine months ended September 30, 2024. 
 
   -- General and administrative expenses were approximately EUR5.2 million for 
      the nine months ended September 30, 2025, compared to approximately 
      EUR4.7 million for the nine months ended September 30, 2024. The increase 
      in general and administrative expenses is mostly due to higher 
      consultancy expenses. 
 
   -- Share of profits of equity accounted investee, after elimination of 
      intercompany transactions, was approximately EUR17 million for the nine 
      months ended September 30, 2025, compared to approximately EUR5.3 million 
      for the nine months ended September 30, 2024. The increase in share of 
      profits of equity accounted investee was mainly due to the recording of a 
      gain on bargain purchase by Ellomay Luzon Energy Infrastructures Ltd. 
      ("Ellomay Luzon Energy"), an equity accounted investee of the Company, in 
      the amount of NIS 112.8 million (approximately EUR28.7 million based on 
      the average EUR/USD exchange rate for the year 2025) in connection with 
      the acquisition on July 22, 2025 of 15% of the outstanding share capital 
      of Dorad Energy Ltd. ("Dorad") by Ellomay Luzon Energy reflecting the 
      excess of the net amount recognized at the acquisition date for the 
      identifiable assets over the cost of the acquired Dorad shares. 
 
   -- Other income, net was approximately EUR1.3 million for the nine months 
      ended September 30, 2025, compared to EUR2.9 for the nine months ended 
      September 30, 2024. The other income recognized for the nine months ended 
      September 30, 2025 is based on agreed compensation expected to be 
      received from the EPC contractor of two of the Company's USA solar 
      facilities for loss of income due to delays in construction and the other 
      income recognized for the nine months ended September 30, 2024 is based 
      on compensation received from insurance in connection with the fire near 
      the Talasol and Ellomay Solar facilities in Spain in July 2024, net of 
      impairment expenses related to the damaged fixed assets. 
 
   -- Financing expense, net was approximately EUR8.7 million for the nine 
      months ended September 30, 2025, compared to financing expense, net of 
      approximately EUR2 million for the nine months ended September 30, 2024. 
      The change in financing expenses, net, was mainly attributable to lower 
      income resulting from exchange rate differences that amounted to 
      approximately EUR1.6 million for the nine months ended September 30, 
      2025, compared to approximately EUR5.2 million for the nine months ended 
      September 30, 2024, an aggregate change of approximately EUR3.5 million. 
      The exchange rate differences were mainly recorded in connection with the 
      New Israeli Shekel ("NIS") cash and cash equivalents and the Company's 
      NIS denominated debentures and were caused by the 2.2% devaluation of the 
      NIS against the euro during the nine months ended September 30, 2025, 
      compared to 3.5% devaluation of the NIS against the euro during the nine 
      months ended September 30, 2024. The increase in financing expense for 
      the nine months ended September 30, 2025 was also attributable to an 
      increase in financing expense of approximately EUR3.4 million in 
      connection with derivatives and warrants for the nine months ended 
      September 30, 2025, compared to the nine months ended September 30, 2024. 
      The increase was partially offset by increased interest income on 
      balances mainly deposited by the Company for short-term periods. 
 
   -- Tax benefit was approximately EUR1.8 million for the nine months ended 
      September 30, 2025, compared to a tax benefit of approximately EUR0.1 
      million for the nine months ended September 30, 2024. The change is 
      primarily attributable to the tax impact of the investment transaction 
      with Clal Insurance Company Ltd. ("Clal") in the Company's 198 MW solar 
      portfolio, which is expected to be fully offset through the utilization 
      of current losses. 
 
   -- Profit for the nine months ended September 30, 2025 was approximately 
      EUR8.5 million, compared to a profit of approximately EUR3.3 million for 
      the nine months ended September 30, 2024. 
 
   -- Total other comprehensive loss was approximately EUR8.6 million for the 
      nine months ended September 30, 2025, compared to total other 
      comprehensive income of approximately EUR2.6 million for the nine months 
      ended September 30, 2024. The change in total other comprehensive income 
      (loss) is primarily as the result of foreign currency translation 
      adjustments due to the change in the NIS/euro exchange rate and by 
      changes in fair value of cash flow hedges, including a material decrease 
      in the fair value of the liability resulting from the financial power 
      swap that covers approximately 80% of the output of the Talasol solar 
      plant (the "Talasol PPA"). The Talasol PPA experienced high volatility 
      due to the substantial change in electricity prices in Europe. In 
      accordance with hedge accounting standards, the changes in the Talasol 
      PPA's fair value are recorded in the Company's shareholders' equity 
      through a hedging reserve and not through the accumulated 
      deficit/retained earnings. The changes do not impact the Company's 
      consolidated net profit/loss or the Company's consolidated cash flows. 
 
   -- Total comprehensive loss was approximately EUR0.1 million for the nine 
      months ended September 30, 2025, compared to total comprehensive income 
      of approximately EUR5.9 million for the nine months ended September 30, 
      2024. 
 
   -- Net cash provided by operating activities was approximately EUR8.5 
      million for the nine months ended September 30, 2025, compared to 
      approximately EUR5.5 million for the nine months ended September 30, 
      2024. The increase in net cash provided by operating activities for the 
      nine months ended September 30, 2025, is mainly due to income produced by 
      the Company's Italian solar facilities that were connected to the grid in 
      February-May 2024 and in January 2025, three of the Company's facilities 
      in Texas USA that were connected to the grid and commenced commissioning 
      tests in April 2024, and 2024 related subsidies that were paid to the 
      Company's Dutch biogas plants in 2025. 
 
   -- In September 2025, the Company received tax credits in respect of two 
      facilities in the USA in an aggregate amount of approximately EUR10 
      million, which were presented as cash flows provided by financing 
      activities. 
 
(1)  The revenues presented in the Company's financial 
      results included in this press release are based on 
      IFRS and do not take into account the adjustments 
      included in the Company's investor presentation. 
 

CEO Review for the First Nine Months of 2025

In the first nine months, the Company's revenues amounted to approximately EUR32.9 million, an increase of approximately 3% in revenues compared to the corresponding period last year. Cash provided by operating activities was approximately EUR8.5 million in the first nine months compared to approximately EUR5.5 million in the corresponding period last year. The EBITDA for the first nine months of 2025 was approximately EUR28.2 million, compared to approximately EUR17.6 million in the corresponding period last year.

In the first nine months of 2025, there was a significant advancement in the construction and connection to the grid of new projects, which are expected to contribute to a significant increase in the Company's revenues during 2026.

In Italy -- 38 MW solar (51% owned in partnership with Clal) are fully operating. The construction work on additional 160 MW solar (51% owned in partnership with Clal) has begun and construction is progressing as planned and is expected to finish by the end of 2026. The remainder of the portfolio developed by the Company (100% owned) is approximately 264 MW solar, of which 210 MW have reached Ready to Build status as of the date hereof and the rest are expected to receive permits in the near future. These 264 MW are scheduled to begin construction in the last quarter of 2026. The Company signed a power purchase agreement $(PPA)$ with a leading European entity for the operating projects with an aggregate capacity of 38 MW and the Company intends to continue to execute PPAs for the remainder of the portfolio.

In the USA -- The construction of the first 4 projects (49 MW) has been completed, three of them were connected to the grid at the end of the first half of 2025 and the fourth project will be connected in the near future. The Company has begun construction of the Hillsboro project (14 MW solar + two hours of battery storage). The Company is examining the possibility of entering into the construction of two additional projects that will fall within the current tax benefit framework. The regulatory changes and the uncertainty regarding tariff rates do not allow the Company to provide a forecast beyond what has been said, but the assumption is that the Company will find a way to continue developing and increasing the portfolio in the near future.

In the Netherlands -- the license to increase production at the GGOT facility was received. Licenses to increase production at the two additional facilities are in advanced stages. The new regulation for the obligation to blend green gas with fossil gas will commence according to the law in January 2027 (a delay of one year), but the targets for the first year have increased. Agreements have been signed for the sale of green certificates issued under the new regulation at a price of approximately EUR1 per certificate. The blending obligation is expected to significantly increase the profitability of operations in the Netherlands at current production capacity. The expected increase in production capacity from 16 million cubic meters of gas per year to around 24 million cubic meters of gas per year is expected to add significantly beyond that.

In Israel -- the Company is in negotiations with the Israeli Electricity Authority for compensation for delays and war damage to the Manara project. Ellomay Luzon (50% owned) exercised its right of refusal in connection with the Zorlu-Phoenix transaction for the sale of Dorad's shares and acquired an additional 15% of Dorad's shares so that its holdings in Dorad are currently 33.75%. Dorad notified of the approval of its board of directors to advance to financial closing of Dorad 2 and the intention is to try to reach financial closing by June 30, 2026.

Dorad finished the third quarter with a profit of approximately NIS 118.4 million, despite a decline of approximately 10% in the USD exchange rate, which caused an accounting expense during the period of approximately NIS 69 million on Dorad's USD deposits. Dorad has future expenses in USD (gas purchases, operation and maintenance payments, construction of Dorad 2) that constitute a natural hedge for the USD deposits. Dorad is actively advancing the establishment of the Dorad 2 project (an expansion of the existing power station using an H-type turbine with a generation capacity of approximately 700 MWh).

In Spain -- The Company's development activity in Spain focuses on energy storage in batteries, whereby the process for obtaining license for Ellomay Solar (28 MWp for two hours of battery storage) is in advanced stages and is expected to be received in the coming months. In addition, the Company is advancing a battery storage project for Talasol (120 MWp). The high volatility in electricity prices in Spain stems from an excess of renewable energy during the transition seasons and causes damage to the stability of the grid. In the Company's assessment, the solution is a significant increase in storage capacity, which is currently at very low levels in Spain.

Use of Non-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company's EBITDA may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 14 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

   -- Approximately 335.9 MW of operating solar power plants in Spain 
      (including a 300 MW solar plant in owned by Talasol, which is 51% owned 
      by the Company) and 51% of approximately 38 MW of operating solar power 
      plants in Italy; 
 
   -- 16.875% indirect interest in Dorad Energy Ltd., which owns and operates 
      one of Israel's largest private power plants with production capacity of 
      approximately 850 MW; 
 
   -- Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland 
      B.V., project companies operating anaerobic digestion plants in the 
      Netherlands, with a green gas production capacity of approximately 3 
      million, 3.8 million and 9.5 million Nm3 per year, respectively; 
 
   -- 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a 
      project to construct a 156 MW pumped storage hydro power plant in the 
      Manara Cliff, Israel; 
 
   -- 51% of solar projects in Italy with an aggregate capacity of 160 MW that 
      are under construction; 
 
   -- Solar projects in Italy with an aggregate capacity of 210 MW that have 
      reached "ready to build" status; and 
 
   -- Solar projects in the Dallas Metropolitan area, Texas, USA with an 
      aggregate capacity of approximately 38 MW that are connected to the grid 
      and additional 11 MW that are awaiting connection to the grid. 

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including changes in electricity prices and demand, regulatory changes increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, the impact of the war and hostilities in Israel and Gaza and between Israel and Iran, the outcome of legal proceedings in connection with Dorad Energy Ltd., technical and other disruptions in the operations or construction of the power plants owned by the Company, inability to obtain the financing required for the development and construction of projects, inability to advance the expansion of Dorad, increases in interest rates and inflation, changes in exchange rates, delays in development, construction, or commencement of operation of the projects under development, failure to obtain permits - whether within the set time frame or at all, climate change, the impact of the continued military conflict between Russia and Ukraine, and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Rubenbach (Weintraub)

CFO

Tel: +972 (3) 797-1111

Email: hilai@ellomay.com

 
                  Ellomay Capital Ltd. and its Subsidiaries 
Unaudited Condensed Consolidated Interim Statements 
 of Financial Position 
----------------------------------------------------------- 
 
                    September     December      September 
                       30,           31,           30, 
                      2025          2024           2025 
                   -----------   -----------   ------------ 
                                               Convenience 
                                               Translation 
                                               into US$ in 
                       EUR in thousands         thousands* 
                   -------------------------   ------------ 
Assets 
Current assets: 
Cash and cash 
 equivalents            49,288        41,134         57,856 
Restricted cash            656           656            770 
Intangible asset 
 from green 
 certificates              419           178            492 
Trade and revenue 
 receivables             5,461         5,393          6,410 
Other receivables       15,212        15,341         17,856 
Derivatives asset 
 short-term                250           146            293 
Other receivables 
 - investment 
 transaction             4,221             -          4,955 
                    ----------   -----------   ------------ 
                        75,507        62,848         88,632 
  ----------------  ----------   -----------   ------------ 
Non-current 
assets 
Investment in 
 equity accounted 
 investee               57,545        41,324         67,548 
Advances on 
 account of 
 investments                 -           547              - 
Fixed assets           528,851       482,747        620,784 
Right-of-use asset      41,579        34,315         48,807 
Restricted cash 
 and deposits           15,940        17,052         18,711 
Deferred tax            11,276         9,039         13,236 
Long-term 
 receivables            16,212        13,411         19,030 
Derivatives             12,534        15,974         14,713 
                    ----------   -----------   ------------ 
                       683,937       614,409        802,829 
  ----------------  ----------   -----------   ------------ 
Total assets           759,444       677,257        891,461 
                    ==========   ===========   ============ 
 
Liabilities and 
Equity 
Current 
liabilities 
Short-term bank 
 loans and current 
 maturities of 
 long-term bank 
 loans                  16,133        21,316         18,937 
Current maturities 
 of other 
 long-term loans         3,666         5,866          4,303 
Current maturities 
 of debentures          12,013        35,706         14,101 
Trade payables          11,995         8,856         14,080 
Other payables          16,533        10,896         19,407 
Current maturities 
 of derivatives            237         1,875            278 
Current maturities 
 of lease 
 liabilities               814           714            956 
Warrants                 2,507         1,446          2,943 
                    ----------   -----------   ------------ 
                        63,898        86,675         75,005 
  ----------------  ----------   -----------   ------------ 
Non-current 
liabilities 
Long-term lease 
 liabilities            33,304        25,324         39,093 
Long-term bank 
 loans                 243,627       245,866        285,978 
Other long-term 
 loans                  42,788        30,448         50,226 
Debentures             194,575       155,823        228,399 
Deferred tax             2,621         2,609          3,077 
Other long-term 
 liabilities             8,186           939          9,609 
Derivatives              1,353           288          1,588 
                    ----------   -----------   ------------ 
                       526,454       461,297        617,970 
  ----------------  ----------   -----------   ------------ 
Total liabilities      590,352       547,972        692,975 
                    ==========   ===========   ============ 
 
Equity 
Share capital           27,998        25,613         32,865 
Share premium           96,568        86,271        113,355 
Treasury shares         (1,736)       (1,736)        (2,038) 
Transaction 
 reserve with 
 non-controlling 
 interests              14,757         5,697         17,322 
Reserves                 6,764        14,338          7,940 
Accumulated 
 deficit                (1,123)      (11,561)        (1,318) 
                    ----------   -----------   ------------ 
Total equity 
 attributed to 
 shareholders of 
 the Company           143,228       118,622        168,126 
Non-controlling 
 interest               25,864        10,663         30,360 
                    ----------   -----------   ------------ 
Total equity           169,092       129,285        198,486 
                    ==========   ===========   ============ 
Total liabilities 
 and equity            759,444       677,257        891,461 
                    ==========   ===========   ============ 
 
 
*  Convenience translation into US$ (exchange rate as 
    at September 30, 2025: euro 1 = US$ 1.174) 
 
 
 
                                                Ellomay Capital Ltd. and its Subsidiaries 
Unaudited Condensed Consolidated Interim Statements 
 of Comprehensive Income 
----------------------------------------------------------------------------------------- 
 
                                                                  For the 
                                                                    year     For the nine 
                                            For the nine months    ended     months ended 
                     For the three months     ended September     December    September 
                     ended September 30,            30,             31,          30, 
                     --------------------   ------------------- 
                       2025       2024       2025       2024        2024         2025 
                     --------   ---------   -------   ---------   --------   ------------ 
                                     Unaudited                    Audited     Unaudited 
                     ------------------------------------------   --------   ------------ 
                                                                             Convenience 
                                                                             Translation 
                           EUR in thousands (except per share data)           into US$* 
                     -----------------------------------------------------   ------------ 
Revenues               12,729      12,333    32,865      31,789     40,467         38,578 
Operating expenses     (5,155)     (4,982)  (14,361)    (14,505)   (19,803)       (16,857) 
Depreciation and 
 amortization 
 expenses              (4,362)     (4,111)  (12,850)    (12,342)   (15,887)       (15,084) 
                      -------   ---------   -------   ---------   --------   ------------ 
Gross profit            3,212       3,240     5,654       4,942      4,777          6,637 
 
Project development 
 costs                   (511)     (1,030)   (3,381)     (3,311)    (4,101)        (3,969) 
General and 
 administrative 
 expenses              (1,781)     (1,645)   (5,165)     (4,679)    (6,063)        (6,063) 
Share of profits of 
 equity accounted 
 investee              16,999       3,486    17,011       5,295     11,062         19,968 
Other income 
 (expenses), net         (153)      2,885     1,278       2,885      3,409          1,500 
                      -------   ---------   -------   ---------   --------   ------------ 
Operating profit       17,766       6,936    15,397       5,132      9,084         18,073 
 
Financing income        7,853       4,553     9,596       6,977      2,495         11,264 
Financing income 
 (expenses) in 
 connection with 
 derivatives and 
 warrants, net         (1,037)        (90)     (599)      2,762      1,140           (703) 
Financing expenses 
 in connection with 
 projects finance      (1,928)     (1,693)   (5,016)     (4,646)    (6,190)        (5,888) 
Financing expenses 
 in connection with 
 debentures              (971)     (1,486)   (4,971)     (5,048)    (6,641)        (5,835) 
Interest expenses on 
 minority 
 shareholder loan        (424)       (528)   (1,355)     (1,616)    (2,144)        (1,591) 
Other financing 
 expenses             (11,209)       (145)   (6,349)       (428)    (8,311)        (7,453) 
                      -------   ---------   -------   ---------   --------   ------------ 
Financing income 
 (expenses), net       (7,716)        611    (8,694)     (1,999)   (19,651)       (10,206) 
                      -------   ---------   -------   ---------   --------   ------------ 
 
Profit before taxes 
 on income             10,050       7,547     6,703       3,133    (10,567)         7,867 
Tax benefit (taxes 
 on income)                19        (916)    1,790          72      1,424          2,101 
                      -------   ---------   -------   ---------   --------   ------------ 
Profit (loss) for 
 the period from 
 continuing 
 operations            10,069       6,631     8,493       3,205     (9,143)         9,968 
                      -------   ---------   -------   ---------   --------   ------------ 
Profit from 
 discontinued 
 operation (net of 
 tax)                       -           -         -          79        137              - 
                      -------   ---------   -------   ---------   --------   ------------ 
Profit (loss) for 
 the period            10,069       6,631     8,493       3,284     (9,006)         9,968 
                      -------   ---------   -------   ---------   --------   ------------ 
Profit (loss) 
attributable to: 
Owners of the 
 Company               10,128       6,104    10,438       4,670     (6,524)        12,252 
Non-controlling 
 interests                (59)        527    (1,945)     (1,386)    (2,482)        (2,284) 
                      -------   ---------   -------   ---------   --------   ------------ 
Profit (loss) for 
 the period            10,069       6,631     8,493       3,284     (9,006)         9,968 
                      -------   ---------   -------   ---------   --------   ------------ 
Other 
comprehensive 
income (loss) item 
that after initial 
recognition in 
comprehensive 
income (loss) were 
or will be 
transferred to 
profit or loss: 
Foreign currency 
 translation 
 differences for 
 foreign operations     2,911      (4,719)   (6,137)     (5,152)     8,007         (7,204) 
Foreign currency 
 translation 
 differences for 
 foreign operations 
 that were 
 recognized in 
 profit or loss             -           -         -         255        255              - 
Effective portion of 
 change in fair 
 value of cash flow 
 hedges                (2,248)        286       386       9,412      5,631            453 
Net change in fair 
 value of cash flow 
 hedges transferred 
 to profit or loss       (539)      1,363    (2,821)     (1,921)      (813)        (3,312) 
                      -------   ---------   -------   ---------   --------   ------------ 
Total other 
 comprehensive 
 income (loss)            124      (3,070)   (8,572)      2,594     13,080        (10,063) 
                      -------   ---------   -------   ---------   --------   ------------ 
 
Total other 
comprehensive 
income (loss) 
attributable to: 
Owners of the 
 Company                1,281      (4,020)   (7,574)     (1,315)    10,039         (8,891) 
Non-controlling 
 interests             (1,157)        950      (998)      3,909      3,041         (1,172) 
                      -------   ---------   -------   ---------   --------   ------------ 
Total other 
 comprehensive 
 income (loss) for 
 the period               124      (3,070)   (8,572)      2,594     13,080        (10,063) 
                      -------   ---------   -------   ---------   --------   ------------ 
Total comprehensive 
 income (loss) for 
 the period            10,193       3,561       (79)      5,878      4,074            (95) 
                      =======   =========   =======   =========   ========   ============ 
 
Total 
comprehensive 
income (loss) 
attributable to: 
Owners of the 
 Company               11,409       2,084     2,864       3,355      3,515          3,361 
Non-controlling 
 interests             (1,216)      1,477    (2,943)      2,523        559         (3,456) 
                      -------   ---------   -------   ---------   --------   ------------ 
Total comprehensive 
 income (loss) for 
 the period            10,193       3,561       (79)      5,878      4,074            (95) 
                      -------   ---------   -------   ---------   --------   ------------ 
 
 
*  Convenience translation into US$ (exchange rate as 
    at September 30, 2025: euro 1 = US $ 1.174) 
 
 
 
                                 Ellomay Capital Ltd. and its Subsidiaries 
Condensed Consolidated Interim Statements of Profit 
 or Loss and Other Comprehensive Income (cont'd) 
-------------------------------------------------------------------------- 
 
                                                   For the 
                                                     year     For the nine 
                 For the three     For the nine     ended     months ended 
                  months ended     months ended    December    September 
                 September 30,     September 30,     31,          30, 
                ----------------  --------------- 
                2025     2024     2025    2024       2024         2025 
                -----  ---------  ----  ---------  --------   ------------ 
                            Unaudited              Audited     Unaudited 
                ---------------------------------  --------   ------------ 
                                                              Convenience 
                                                              Translation 
                 EUR in thousands (except per share data)      into US$* 
                -------------------------------------------   ------------ 
Basic profit 
 (loss) per 
 share           0.79       0.47  0.81       0.36     (0.51)          0.95 
Diluted profit 
 (loss) per 
 share           0.79       0.47  0.81       0.36     (0.51)          0.95 
                 ====  =========  ====  =========  ========   ============ 
 
Basic profit 
 (loss) per 
 share 
 continuing 
 operations      0.79       0.47  0.81       0.35     (0.52)          0.95 
                 ====  =========  ====  =========  ========   ============ 
Diluted profit 
 (loss) per 
 share 
 continuing 
 operations      0.79       0.47  0.81       0.35     (0.52)          0.95 
                 ====  =========  ====  =========  ========   ============ 
 
Basic profit 
 per share 
 discontinued 
 operation          -          -     -       0.01      0.01              - 
                 ====  =========  ====  =========  ========   ============ 
Diluted profit 
 per share 
 discontinued 
 operation          -          -     -       0.01      0.01              - 
                 ====  =========  ====  =========  ========   ============ 
 
 
*  Convenience translation into US$ (exchange rate as 
    at September 30, 2025: euro 1 = US$ 1.174) 
 
 
 
                                                                                                             Ellomay Capital Ltd. and its Subsidiaries 
Unaudited Condensed Consolidated Interim Statements 
 of Changes in Equity 
------------------------------------------------------------------------------------------------------------------------------------------------------ 
 
                                                                                                                               Non- 
                                                                                                                            controlling 
                                                          Attributable to shareholders of the Company                        Interests    Total Equity 
                                      -----------------------------------------------------------------------------------   -----------   ------------ 
                                                                         Translation 
                                                                           reserve                 Transaction 
                                        Retained earnings                   from                  reserve with 
                    Share     Share       (accumulated        Treasury     foreign     Hedging   non-controlling 
                   capital   premium        Deficit)           shares    operations    Reserve      interests      Total 
                   --------  -------  ---------------------   --------   -----------   -------   ---------------  ------- 
                                                                            EUR in thousands 
                   ----------------------------------------------------------------------------------------------------------------------------------- 
For the nine 
months ended 
September 30, 
2025 
(unaudited): 
Balance as at 
 January 1, 2025     25,613   86,271                (11,561)    (1,736)        8,446     5,892             5,697  118,622        10,663        129,285 
Profit for the 
 period                                              10,438                                                        10,438        (1,945)         8,493 
Other 
 comprehensive 
 loss for the 
 period                                                              -        (6,220)   (1,354)                    (7,574)         (998)        (8,572) 
                    -------  -------  ---------------------   --------   -----------   -------   ---------------  -------   -----------   ------------ 
Total 
 comprehensive 
 loss for the 
 period                   -        -                 10,438          -        (6,220)   (1,354)                -    2,864        (2,943)           (79) 
Transactions 
with owners of 
the Company, 
recognized 
directly in 
equity: 
Sale of shares in 
 subsidiaries from 
 non-controlling 
 interests                -        -                      -          -             -         -             9,060    9,060        16,997         26,057 
Options exercise          3        5                      -          -             -         -                 -        8             -              8 
Issuance of 
 ordinary shares      2,382   10,281                      -          -            --         -                 -   12,663             -         12,663 
Issuance of 
 capital note to 
 non-controlling 
 interest                 -        -                      -          -             -         -                 -        -         1,147          1,147 
Share-based 
 payments                 -       11                      -          -             -         -                 -       11             -             11 
                    -------  -------  ---------------------   --------   -----------   -------   ---------------  -------   -----------   ------------ 
Balance as at 
 September 30, 
 2025                27,998   96,568                 (1,123)    (1,736)        2,226     4,538            14,757  143,228        25,864        169,092 
                    =======  =======  =====================   ========   ===========   =======   ===============  =======   ===========   ============ 
 
For the nine 
months ended 
September 30, 
2024 
(unaudited): 
Balance as at 
 January 1, 2024     25,613   86,159                 (5,037)    (1,736)          385     3,914             5,697  114,995        10,104        125,099 
Profit (loss) for 
 the period               -        -                  4,670          -             -         -                 -    4,670        (1,386)         3,284 
Other 
 comprehensive 
 income (loss) for 
 the period               -        -                      -          -        (4,762)    3,447                 -   (1,315)        3,909          2,594 
Total 
 comprehensive 
 income (loss) for 
 the period               -        -                  4,670          -        (4,762)    3,447                 -    3,355         2,523          5,878 
                    -------  -------  ---------------------   --------   -----------   -------   ---------------  -------   -----------   ------------ 
Transactions 
with owners of 
the Company, 
recognized 
directly in 
equity: 
Share-based 
 payments                 -       91                      -          -             -         -                 -       91             -             91 
                    -------  -------  ---------------------   --------   -----------   -------   ---------------  -------   -----------   ------------ 
Balance as at 
 September 30, 
 2024                25,613   86,250                   (367)    (1,736)       (4,377)    7,361             5,697  118,441        12,627        131,068 
                    =======  =======  =====================   ========   ===========   =======   ===============  =======   ===========   ============ 
 
 
 
                                                                                          Ellomay Capital Ltd. and its Subsidiaries 
Unaudited Condensed Consolidated Interim Statements 
 of Changes in Equity (cont'd) 
----------------------------------------------------------------------------------------------------------------------------------- 
 
                                                                                                                 Non- 
                                                                                                              controlling    Total 
                                                  Attributable to shareholders of the Company                  Interests    Equity 
                                    -----------------------------------------------------------------------   -----------   ------- 
                                                             Translation 
                                                               reserve               Transaction 
                                                                from                reserve with 
                  Share     Share   Accumulated   Treasury     foreign    Hedging  non-controlling 
                 capital   premium    deficit      shares    operations   Reserve     interests      Total 
                 --------  -------  -----------   --------   -----------  -------  ---------------  ------- 
                                                                  EUR in thousands 
                 ------------------------------------------------------------------------------------------------------------------ 
For the year 
ended December 
31, 2024 
(audited): 
Balance as at 
 January 1, 
 2024              25,613   86,159       (5,037)    (1,736)          385    3,914            5,697  114,995        10,104   125,099 
Loss for the 
 year                   -        -       (6,524)         -             -        -                -   (6,524)       (2,482)   (9,006) 
Other 
 comprehensive 
 income for the 
 year                   -        -            -          -         8,061    1,978                -   10,039         3,041    13,080 
                  -------  -------  -----------   --------   -----------  -------  ---------------  -------   -----------   ------- 
Total 
 comprehensive 
 income (loss) 
 for the year           -        -       (6,524)         -         8,061    1,978                -    3,515           559     4,074 
Transactions 
with owners of 
the Company, 
recognized 
directly in 
equity: 
Share-based 
 payments               -      112            -          -             -        -                -      112             -       112 
                  -------  -------  -----------   --------   -----------  -------  ---------------  -------   -----------   ------- 
Balance as at 
 December 31, 
 2024              25,613   86,271      (11,561)    (1,736)        8,446    5,892            5,697  118,622        10,663   129,285 
                  =======  =======  ===========   ========   ===========  =======  ===============  =======   ===========   ======= 
 
 
 
                                                                                              Ellomay Capital Ltd. and its Subsidiaries 
Unaudited Condensed Consolidated Interim Statements 
 of Changes in Equity (cont'd) 
--------------------------------------------------------------------------------------------------------------------------------------- 
 
                                                                                                                     Non- 
                                                                                                                  controlling    Total 
                                                     Attributable to shareholders of the Company                   Interests    Equity 
                                      -------------------------------------------------------------------------   -----------   ------- 
                                                               Translation 
                                                                 reserve                 Transaction 
                                                                  from                  reserve with 
                    Share     Share   Accumulated   Treasury     foreign     Hedging   non-controlling 
                   capital   premium    deficit      shares    operations    Reserve      interests      Total 
                   --------  -------  -----------   --------   -----------   -------   ---------------  ------- 
                                                    Convenience translation into US$ (exchange rate as 
                                                         at September 30, 2025: euro 1 = US$1.174) 
                   -------------------------------------------------------------------------------------------------------------------- 
For the nine 
months ended 
September 30, 
2025 
(unaudited): 
Balance as at 
 January 1, 2025     30,065  101,268      (13,570)    (2,038)        9,915     6,916             6,687  139,243        12,518   151,761 
Profit for the 
 period                   -        -       12,252          -             -         -                 -   12,252        (2,284)    9,968 
Other 
 comprehensive 
 loss for the 
 period                   -        -            -          -        (7,301)   (1,590)                -   (8,891)       (1,172)  (10,063) 
                    -------  -------  -----------   --------   -----------   -------   ---------------  -------   -----------   ------- 
Total 
 comprehensive 
 loss for the 
 period                   -        -       12,252          -        (7,301)   (1,590)                -    3,361        (3,456)      (95) 
Transactions 
with owners of 
the Company, 
recognized 
directly in 
equity: 
Sale of shares in 
 subsidiaries from 
 non-controlling 
 interests                -        -            -          -             -         -            10,635   10,635        19,952    30,587 
Options exercise          4        6            -          -             -         -                 -       10             -        10 
Issuance of 
 ordinary shares      2,796   12,068            -          -             -         -                 -   14,864             -    14,864 
Issuance of 
 capital note to 
 non-controlling 
 interest                 -        -            -          -             -         -                 -        -         1,346     1,346 
Share-based 
 payments                 -       13            -          -             -         -                 -       13             -        13 
                    -------  -------  -----------   --------   -----------   -------   ---------------  -------   -----------   ------- 
Balance as at 
 September 30, 
 2025                32,865  113,355       (1,318)    (2,038)        2,614     5,326            17,322  168,126        30,360   198,486 
                    =======  =======  ===========   ========   ===========   =======   ===============  =======   ===========   ======= 
 
 
 
                                             Ellomay Capital Ltd. and its Subsidiaries 
Unaudited Condensed Consolidated Interim Statements 
 of Cash Flow 
-------------------------------------------------------------------------------------- 
 
                                                                For the      For the 
                                                                  year     nine months 
                                          For the nine months    ended        ended 
                   For the three months     ended September     December    September 
                   ended September 30,            30,             31,          30, 
                   --------------------   ------------------- 
                     2025       2024       2025       2024        2024        2025 
                   --------   ---------   -------   ---------   --------   ----------- 
                                                                           Convenience 
                                                                           Translation 
                                     EUR in thousands                       into US$* 
                   -----------------------------------------------------   ----------- 
Cash flows from 
operating 
activities 
Profit (loss) for 
 the period          10,069       6,631     8,493       3,284     (9,006)        9,968 
Adjustments for: 
---------------- 
Financing income 
 (expenses), net      7,716        (611)    8,694       1,595     19,247        10,206 
Profit (loss) from 
 settlement of 
 derivatives 
 contract                 -        (149)        -          50        316             - 
Impairment losses 
 on assets of 
 disposal groups 
 classified as 
 held-for-sale            -           -         -         405        405             - 
Depreciation and 
 amortization         4,362       4,111    12,850      12,390     15,935        15,084 
Share-based 
 payment 
 transactions             7          30        11          91        112            13 
Share of profits 
 of equity 
 accounted 
 investees          (16,999)     (3,486)  (17,011)     (5,295)   (11,062)      (19,968) 
Change in trade 
 receivables and 
 other 
 receivables         (1,083)         (4)    6,302      (3,218)    (8,824)        7,398 
Change in other 
 assets                 469         871      (533)        876      3,770          (626) 
Change in 
 receivables from 
 concessions 
 project                  -           -         -         793        793             - 
Change in trade 
 payables              (501)        554     2,177         (79)       (31)        2,555 
Change in other 
 payables             1,293      (2,052)   (3,517)       (293)     4,455        (4,128) 
Income tax expense 
 (tax benefit)          (19)        916    (1,790)        (77)    (1,429)       (2,101) 
Income taxes 
 refund (paid)            7        (133)      (20)        346        623           (23) 
Interest received       878         226     2,222       1,932      2,537         2,608 
Interest paid        (2,721)     (1,827)   (9,347)     (7,255)    (9,873)      (10,972) 
                    -------   ---------   -------   ---------   --------   ----------- 
                     (6,591)     (1,554)       38       2,261     16,974            46 
  ----------------  -------   ---------   -------   ---------   --------   ----------- 
Net cash provided 
 by operating 
 activities           3,478       5,077     8,531       5,545      7,968        10,014 
                    =======   =========   =======   =========   ========   =========== 
 
Cash flows from 
investing 
activities 
Acquisition of 
 fixed assets       (22,106)    (30,453)  (59,036)    (50,046)   (72,922)      (69,299) 
Interest paid 
 capitalized to 
 fixed assets        (2,071)       (507)   (3,898)     (1,628)    (2,515)       (4,576) 
Proceeds from sale 
 of investments           -           -         -       9,267      9,267             - 
Advances on 
 account of 
 investments            547        (109)      547        (163)      (163)          642 
Proceeds from 
 advances on 
 account of 
 investments              -           -         -           -        514             - 
Proceeds from 
 (investment in) 
 settlement of 
 derivatives, net         -          65         -         224       (316)            - 
Proceeds from 
 restricted cash, 
 net                 10,530          38     1,364         157        689         1,601 
Proceeds from 
 (investment in) 
 short term 
 deposit                  -          79         -      (1,404)     1,004             - 
                    -------   ---------   -------   ---------   --------   ----------- 
Net cash used in 
 investing 
 activities         (13,100)    (30,887)  (61,023)    (43,593)   (64,442)      (71,632) 
                    =======   =========   =======   =========   ========   =========== 
 
Cash flows from 
financing 
activities 
Issuance of 
 warrants                 -           -       475       3,735      2,449           558 
Cost associated 
 with long-term 
 loans               (1,445)       (545)   (2,502)     (2,011)    (2,567)       (2,937) 
Proceeds from 
 option exercise          8           -         8           -          -             9 
Proceeds from 
 private placement 
 of shares           12,663           -    12,663           -          -        14,864 
Sale of shares in 
 subsidiaries to 
 non-controlling 
 interests           12,214           -    33,066           -          -        38,814 
Payment of 
 principal of 
 lease 
 liabilities           (279)       (179)     (731)       (665)    (2,941)         (858) 
Proceeds from long 
 and short-term 
 loans                1,129       8,829    19,028      19,307     19,482        22,336 
Repayment of 
 long-term loans    (23,387)       (441)  (30,140)     (7,108)   (11,776)      (35,379) 
Repayment of 
 debentures               -           -   (35,691)    (35,845)   (35,845)      (41,895) 
Proceeds from the 
 sale of tax 
 credits             10,160           -    10,160           -          -        11,926 
Proceeds from 
 issuance of 
 debentures, net          -      11,966    56,729      57,756     74,159        66,591 
                    -------   ---------   -------   ---------   --------   ----------- 
Net cash provided 
 by financing 
 activities          11,063      19,630    63,065      35,169     42,961        74,029 
                    -------   ---------   -------   ---------   --------   ----------- 
 
Effect of exchange 
 rate fluctuations 
 on cash and cash 
 equivalents          1,347      (1,408)   (2,419)       (220)     3,092        (2,840) 
                    -------   ---------   -------   ---------   --------   ----------- 
Increase 
 (decrease) in 
 cash and cash 
 equivalents          2,788      (7,588)    8,154      (3,099)   (10,421)        9,571 
Cash and cash 
 equivalents at 
 the beginning of 
 the period          46,500      56,044    41,134      51,127     51,127        48,285 
Cash from (used 
 in) disposal 
 groups classified 
 as held-for-sale         -           -         -         428        428             - 
                    -------   ---------   -------   ---------   --------   ----------- 
Cash and cash 
 equivalents at 
 the end of the 
 period              49,288      48,456    49,288      48,456     41,134        57,856 
                    =======   =========   =======   =========   ========   =========== 
 
 
*  Convenience translation into US$ (exchange rate as 
    at September 30, 2025: euro 1 = US$ 1.174) 
 
 
 
                                                                                                         Ellomay Capital Ltd. and its Subsidiaries 
Operating Segments (Unaudited) 
-------------------------------------------------------------------------------------------------------------------------------------------------- 
 
                   Italy                 Spain                USA     Netherlands        Israel          Total 
                  --------   -----------------------------   ------   -----------   ----------------- 
                             Subsidized   28 MV                                                        reportable                        Total 
                   Solar       Plants     Solar    Talasol   Solar      Biogas       Dorad    Manara    segments    Reconciliations   consolidated 
                  --------   ----------   ------   -------   ------   -----------   -------   -------  ----------   ---------------   ------------ 
                                                            For the nine months ended September 30, 2025 
                  -------------------------------------------------------------------------------------------------------------------------------- 
                                                                          EUR in thousands 
                  -------------------------------------------------------------------------------------------------------------------------------- 
 
Revenues             3,801        2,233    1,171    14,800      542        10,318    50,016         -      82,881           (50,016)        32,865 
Operating 
 expenses             (404)        (394)    (533)   (3,604)    (342)       (9,085)  (37,276)        -     (51,638)           37,277        (14,361) 
Depreciation 
 expenses             (674)        (690)    (757)   (8,520)    (309)       (1,840)   (4,026)        -     (16,816)            3,966        (12,850) 
                   -------   ----------   ------   -------   ------   -----------   -------   -------  ----------   ---------------   ------------ 
Gross profit 
 (loss)              2,723        1,149     (119)    2,676     (109)         (607)    8,714         -      14,427            (8,773)         5,654 
 
Project 
 development 
 costs                                                                                                                                      (3,381) 
General and 
 administrative 
 expenses                                                                                                                                   (5,165) 
Share of profit 
 of equity 
 accounted 
 investee                                                                                                                                   17,011 
Other income, net                                                                                                                            1,278 
                                                                                                                                      ------------ 
Operating profit                                                                                                                            15,397 
Financing income                                                                                                                             9,596 
Financing income 
 in connection 
 with derivatives 
 and warrants, 
 net                                                                                                                                          (599) 
Financing 
 expenses in 
 connection with 
 projects 
 finance                                                                                                                                    (5,016) 
Financing 
 expenses in 
 connection with 
 debentures                                                                                                                                 (4,971) 
Interest expenses 
 on minority 
 shareholder 
 loan                                                                                                                                       (1,355) 
Other financing 
 expenses                                                                                                                                   (6,349) 
Financing 
 expenses, net                                                                                                                              (8,694) 
                                                                                                                                      ------------ 
Profit before 
 taxes on income                                                                                                                             6,703 
 
Segment assets as 
 at September 30, 
 2025              118,581       12,962   18,919   215,474   72,331        30,083   114,738   191,501     774,589           (15,145)       759,444 
 
 
 
                                         Ellomay Capital Ltd. and its Subsidiaries 
Reconciliation of Profit (Loss) to EBITDA (Unaudited) 
---------------------------------------------------------------------------------- 
 
                                                            For the      For the 
                                                              year     nine months 
                    For the three         For the nine       ended        ended 
                    months ended          months ended      December    September 
                    September 30,        September 30,        31,          30, 
                 -------------------   ------------------ 
                  2025       2024       2025      2024        2024        2025 
                 -------   ---------   ------   ---------   --------   ----------- 
                                                                       Convenience 
                                                                       Translation 
                                                                       into US$ in 
                                  EUR in thousands                     thousands* 
                 ---------------------------------------------------   ----------- 
Net profit 
 (loss) for the 
 period           10,069       6,631    8,493       3,284     (9,006)        9,968 
Financing 
 (income) 
 expenses, net     7,716        (611)   8,694       1,999     19,651        10,206 
Taxes on income 
 (Tax benefit)       (19)        916   (1,790)        (72)    (1,424)       (2,101) 
Depreciation and 
 amortization      4,362       4,111   12,850      12,342     15,887        15,084 
                  ------   ---------   ------   ---------   --------   ----------- 
EBITDA            22,128      11,047   28,247      17,553     25,108        33,157 
 
 
*  Convenience translation into US$ (exchange rate as 
    at September 30, 2025: euro 1 = US$ 1.174) 
 
 
                           Ellomay Capital Ltd. 
Information for the Company's Debenture Holders 
----------------------------------------------- 
 
 

Financial Covenants

Pursuant to the Deeds of Trust governing the Company's Series D, Series E, Series F and Series G Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 30, 2025, and below.

Net Financial Debt

As of September 30, 2025, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately EUR164.1 million (consisting of approximately EUR310.7(2) million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately EUR213.4(3) million in connection with (i) the Series D Convertible Debentures issuance (in February 2021), (ii) the Series E Secured Debentures issuance (in February 2023), (iii) the Series F Debentures issuance (in January, April, August and November 2024) and (iv) the Series G Debentures issuance (in February 2025)), net of approximately EUR49.3 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately EUR310.7(4) million of project finance and related hedging transactions of the Company's subsidiaries). The Net Financial Debt and other information included in this disclosure do not include the private placement of Series G Debentures consummated in December 2025.

 
(2)  The amount of short-term and long-term debt from banks 
      and other interest-bearing financial obligations provided 
      above, includes an amount of approximately EUR4.3 
      million costs associated with such debt, which was 
      capitalized and therefore offset from the debt amount 
      that is recorded in the Company's balance sheet. 
 
(3)  The amount of the debentures provided above includes 
      an amount of approximately EUR5.9 million associated 
      costs, which was capitalized and discount or premium 
      and therefore offset from the debentures amount that 
      is recorded in the Company's balance sheet. This amount 
      also includes the accrued interest as at September 
      30, 2025 in the amount of approximately EUR0.9 million. 
 
(4)  The project finance amount deducted from the calculation 
      of Net Financial Debt includes project finance obtained 
      from various sources, including financing entities 
      and the minority shareholders in project companies 
      held by the Company (provided in the form of shareholders' 
      loans to the project companies). 
 
 
                                    Ellomay Capital Ltd. 
Information for the Company's Debenture Holders (cont'd) 
-------------------------------------------------------- 
 
 

Information for the Company's Series D Debenture Holders

The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately EUR160.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 50.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(5) was 4.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended September 30, 2025:

 
                                     For the four-quarter period ended 
                                             September 30, 2025 
                                     ---------------------------------- 
                                                 Unaudited 
                                     ---------------------------------- 
                                              EUR in thousands 
                                     ---------------------------------- 
Profit for the period                                             7,268 
Financing expenses, net                                          22,514 
Taxes on income                                                  (2,466) 
Depreciation and amortization 
 expenses                                                        12,711 
Share-based payments                                                  4 
Adjustment to data relating to 
 projects with a Commercial 
 Operation Date during the four 
 preceding quarters(6)                                            1,419 
                                      --------------------------------- 
Adjusted EBITDA as defined the 
 Series D Deed of Trust                                          41,450 
 
 
(5)  The term "Adjusted EBITDA" is defined in the Series 
      D Deed of Trust as earnings before financial expenses, 
      net, taxes, depreciation and amortization, where the 
      revenues from the Company's operations, such as the 
      Talmei Yosef PV Plant, are calculated based on the 
      fixed asset model and not based on the financial asset 
      model (IFRIC 12), and before share-based payments, 
      when the data of assets or projects whose Commercial 
      Operation Date (as such term is defined in the Series 
      D Deed of Trust) occurred in the four quarters that 
      preceded the relevant date will be calculated based 
      on Annual Gross Up (as such term is defined in the 
      Series D Deed of Trust). The Series D Deed of Trust 
      provides that for purposes of the financial covenant, 
      the Adjusted EBITDA will be calculated based on the 
      four preceding quarters, in the aggregate. The Adjusted 
      EBITDA is presented in this press release as part 
      of the Company's undertakings towards the holders 
      of its Series D Debentures. For a general discussion 
      of the use of non-IFRS measures, such as EBITDA and 
      Adjusted EBITDA see above under "Use of NON-IFRS Financial 
      Measures." 
 
(6)  The adjustment is based on the results of a solar 
      plant in Italy and solar plants in the USA that were 
      connected to the grid and commenced delivery of electricity 
      to the grid during the four quarters preceding September 
      30, 2025. The Company records revenues and only direct 
      expenses in connection with solar plants from the 
      connection to the grid and until preliminary acceptance 
      certificate (PAC). However, for the sake of caution, 
      the Company included the expected fixed expenses in 
      connection with solar plants that have not reached 
      PAC yet in the calculation of the adjustment. 
 
 
                                    Ellomay Capital Ltd. 
Information for the Company's Debenture Holders (cont'd) 
-------------------------------------------------------- 
 
 

Information for the Company's Series E Debenture Holders

The Deed of Trust governing the Company's Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series E Deed of Trust) was approximately EUR160.2 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 50.6%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(7) was 4.

The following is a reconciliation between the Company's profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended September 30, 2025:

 
                                     For the four-quarter period ended 
                                             September 30, 2025 
                                     ---------------------------------- 
                                                 Unaudited 
                                     ---------------------------------- 
                                              EUR in thousands 
                                     ---------------------------------- 
Profit for the period                                             7,268 
Financing expenses, net                                          22,514 
Taxes on income                                                  (2,466) 
Depreciation and amortization 
 expenses                                                        12,711 
Share-based payments                                                  4 
Adjustment to data relating to 
 projects with a Commercial 
 Operation Date during the four 
 preceding quarters(8)                                            1,419 
                                      --------------------------------- 
Adjusted EBITDA as defined the 
 Series E Deed of Trust                                          41,450 
 
 

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. ("Ellomay Luzon Energy")), if any, which were pledged to the holders of the Company's Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of September 30, 2025, the value of the assets pledged to the holders of the Series E Debentures in the Company's books (unaudited) is approximately EUR57.5 million (approximately NIS 223.3 million based on the exchange rate as of such date).

 
(7)  The term "Adjusted EBITDA" is defined in the Series 
      E Deed of Trust as earnings before financial expenses, 
      net, taxes, depreciation and amortization, where the 
      revenues from the Company's operations, such as the 
      Talmei Yosef PV Plant, are calculated based on the 
      fixed asset model and not based on the financial asset 
      model (IFRIC 12), and before share-based payments, 
      when the data of assets or projects whose Commercial 
      Operation Date (as such term is defined in the Series 
      E Deed of Trust) occurred in the four quarters that 
      preceded the relevant date will be calculated based 
      on Annual Gross Up (as such term is defined in the 
      Series E Deed of Trust). The Series E Deed of Trust 
      provides that for purposes of the financial covenant, 
      the Adjusted EBITDA will be calculated based on the 
      four preceding quarters, in the aggregate. The Adjusted 
      EBITDA is presented in this press release as part 
      of the Company's undertakings towards the holders 
      of its Series E Debentures. For a general discussion 
      of the use of non-IFRS measures, such as EBITDA and 
      Adjusted EBITDA see above under "Use of NON-IFRS Financial 
      Measures." 
 
(8)  The adjustment is based on the results of a solar 
      plant in Italy and solar plants in the USA that were 
      connected to the grid and commenced delivery of electricity 
      to the grid during the four quarters preceding September 
      30, 2025. The Company records revenues and only direct 
      expenses in connection with solar plants from the 
      connection to the grid and until preliminary acceptance 
      certificate (PAC). However, for the sake of caution, 
      the Company included the expected fixed expenses in 
      connection with solar plants that have not reached 
      PAC yet in the calculation of the adjustment. 
 
 
                                    Ellomay Capital Ltd. 
Information for the Company's Debenture Holders (cont'd) 
-------------------------------------------------------- 
 
 

Information for the Company's Series F Debenture Holders

The Deed of Trust governing the Company's Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series F Deed of Trust) was approximately EUR159.6 million, (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's Adjusted Shareholders' Equity plus the Net Financial Debt) was 50.7%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA(9) was 4.

(MORE TO FOLLOW) Dow Jones Newswires

December 30, 2025 16:31 ET (21:31 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment